However, in the long term–in the presence of continuous neuroinflammation–chronic IDO-1 activation becomes harmful since the consequential release of chronic neuroactive metabolites contributes to the neurodegeneration observed during MS progression (Lim et al., 2010, 2017). This evidence concerns the gene IDO1 and myeloid sarcoma.